Last mentioned: Mar 26, 2026
King County Resolution
King County Council officially passes the resolution to decriminalize psychedelic mushrooms county-wide.
Missouri Pause Request
DOJ files a request in federal court to pause the Missouri-led lawsuit citing an ongoing FDA review.
Public Confirmation
Stryker issues official statements confirming the disruption and the ongoing forensic investigation.
Group Claims Responsibility
The Iran-linked group Handala publicly claims responsibility for the attack on social media platforms.
Network Shutdown
Company initiates a global shutdown of internal networks to contain the spread of suspected wiper malware.
Initial Detection
Stryker IT security teams detect unauthorized access and anomalous activity on global servers.
Hawley Federal Bill
Senator Josh Hawley introduces a bill in the Senate to ban mifepristone nationwide.
Heartbeat Ban Enacted
Wyoming implements new restrictions based on detectable fetal cardiac activity.
Louisiana Pause Request
DOJ asks Louisiana to pause its separate lawsuit; request is rejected by AG Liz Murrill.
Missouri Lawsuit Filed
Missouri, Kansas, and Idaho file suit against the FDA to restrict mifepristone access.
Judicial Injunction
State courts maintain blocks on previous total and medication-specific abortion bans.
WA SB 5263 Passed
Washington Governor signs a bill to create a psilocybin task force and pilot program.
Medication Ban Attempt
Wyoming Governor signs the first U.S. law specifically banning abortion pills.
Dobbs Decision
U.S. Supreme Court overturns Roe v. Wade, returning abortion regulation to states.
Seattle Decriminalization
Seattle City Council passes a resolution to decriminalize the cultivation and possession of psychedelic plants.
King County has officially passed a resolution to decriminalize the possession and use of psychedelic mushrooms, joining a growing list of Pacific Northwest jurisdictions. This move reflects a significant shift toward viewing psilocybin through a public health lens, potentially paving the way for expanded clinical research and therapeutic access in the region.
The Department of Justice has requested a federal court to pause a multi-state lawsuit against the FDA regarding the abortion pill mifepristone. The move suggests a strategic effort to allow the FDA to conduct its own internal review of the drug's safety and distribution protocols.
Medical technology giant Stryker (SYK) has confirmed a massive cyberattack that has disrupted its global networks and forced the closure of its Michigan headquarters. The attack, attributed to the Iran-linked group Handala, reportedly involves destructive wiper malware targeting the company's critical infrastructure.
Wyoming has implemented a ban on abortions once a fetal heartbeat is detected, significantly narrowing the window for legal procedures and medication access. The move triggers immediate concerns for healthcare providers and sets the stage for a protracted legal battle over reproductive rights and pharmaceutical distribution.
This page surfaces every story mentioning FDA across our biotech coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running biotech beat. Cross-entity comparisons live on our compare view.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where FDA was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |